Medicare Enrolled
Dr. Mark Honzel, M.D.
Optician · Beverly Hills, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Honzel from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Honzel?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Honzel
Dr. Mark Honzel is an optician specialist in Beverly Hills, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Honzel performed 2,961 Medicare services across 541 unique beneficiaries.
Between the years covered by Open Payments, Dr. Honzel received a total of $24,398 from 70 pharmaceutical and/or device companies across 1201 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Honzel is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 28% volume in CA
$24,398 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,961
Medicare services
Top 28% in CA for optician
541
Unique beneficiaries
$33
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~156 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Anti-nausea injection (ondansetron/Zofran) | 968 | $0 | $5 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
332 | $75 | $150 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
299 | $72 | $300 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
255 | $18 | $250 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
159 | $8 | $20 |
| Methylprednisolone acetate injection, 20 mg A 20 mg injection of methylprednisolone acetate, a corticosteroid medication. This code specifies the drug and dosage administered. |
136 | $5 | $25 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
135 | $105 | $350 |
| Telephone medical discussion, 5-10 minutes A phone conversation with a physician lasting between 5 and 10 minutes to discuss medical matters. |
124 | $46 | $95 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
122 | $59 | $250 |
| Intravenous drug injection A procedure involving the administration of a medication or substance directly into a vein. |
121 | $34 | $200 |
| Telephone medical discussion, 21-30 minutes A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone. |
85 | $104 | $210 |
| Normal saline infusion, 500 ml Administration of sterile normal saline solution through an intravenous line. This procedure involves the infusion of a 500 ml unit of the solution. |
80 | $1 | $40 |
| Venipuncture for blood draw Insertion of a needle into a vein to collect blood samples. This procedure is performed on patients aged 3 years or older. |
67 | $13 | $400 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
42 | $45 | $280 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
22 | $33 | $40 |
| Flu vaccine, quadrivalent A flu shot containing four strains of the influenza virus to help prevent seasonal influenza infection. |
14 | $75 | $95 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
15.4% high complexity
41.4% medium
43.2% routine
Industry Payment Transparency
Open Payments through 2024 ↗$24,398
Total received (2018-2024)
Avg $3,485/year across 7 years
Top 8% in CA for optician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
70
Companies
1,201
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$24,272 (99.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$127 (0.5%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$4,821
2023
$4,134
2022
$3,039
2021
$4,512
2020
$2,878
2019
$2,621
2018
$2,393
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$511
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$454
ViiV Healthcare Company
$395
Gilead Sciences, Inc.
$349
Lundbeck LLC
$346
Janssen Pharmaceuticals, Inc
$258
Axsome Therapeutics, Inc.
$246
Otsuka America Pharmaceutical, Inc.
$239
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$234
Vanda Pharmaceuticals Inc.
$234
Alkermes, Inc.
$199
Indivior Inc.
$197
Takeda Pharmaceuticals U.S.A., Inc.
$153
Almatica Pharma LLC
$149
IDORSIA PHARMACEUTICALS US INC
$144
Napo Pharmaceuticals Inc
$113
Braeburn Inc.
$111
Bausch Health US, LLC
$95
Amgen Inc.
$78
Theratechnologies Inc.
$59
EMD Serono, Inc.
$59
Merck Sharp & Dohme LLC
$57
Boehringer Ingelheim Pharmaceuticals, Inc.
$33
Teva Pharmaceuticals USA, Inc.
$32
Grifols USA, LLC
$28
E.R. Squibb & Sons, L.L.C.
$27
Lilly USA, LLC
$21
Top 3 companies account for 28.2% of 2024 payments
All-time payments by company (2018-2024) ›
Gilead Sciences, Inc.
$2,841
ViiV Healthcare Company
$1,614
Lundbeck LLC
$1,545
Takeda Pharmaceuticals U.S.A., Inc.
$1,527
ABBVIE INC.
$1,343
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$1,170
AbbVie Inc.
$1,165
Otsuka America Pharmaceutical, Inc.
$1,157
ITI, Inc.
$1,110
Janssen Pharmaceuticals, Inc
$1,006
Vanda Pharmaceuticals Inc.
$794
Sunovion Pharmaceuticals Inc.
$638
Alkermes, Inc.
$575
Almatica Pharma LLC
$560
EMD Serono, Inc.
$539
Theratechnologies Inc.
$471
Janssen Biotech, Inc.
$466
Indivior Inc.
$461
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$454
Napo Pharmaceuticals Inc
$367
IDORSIA PHARMACEUTICALS US INC
$363
Axsome Therapeutics, Inc.
$363
AbbVie, Inc.
$357
Neurocrine Biosciences, Inc.
$336
Bausch Health US, LLC
$209
Orexo US, Inc.
$207
Teva Pharmaceuticals USA, Inc.
$202
Merck Sharp & Dohme Corporation
$188
Merck Sharp & Dohme LLC
$186
Neuronetics, Inc.
$183
Allergan Inc.
$178
Lilly USA, LLC
$146
Allergan, Inc.
$124
AstraZeneca Pharmaceuticals LP
$121
Braeburn Inc.
$111
Antares Pharma, Inc.
$105
Amgen Inc.
$93
Shire North American Group Inc
$87
Biohaven Pharmaceuticals, Inc.
$86
Tris Pharma Inc
$85
Adlon Therapeutics L.P.
$71
Kaleo, Inc.
$67
Eisai Inc.
$52
JAZZ PHARMACEUTICALS INC.
$38
Supernus Pharmaceuticals, Inc.
$37
PFIZER INC.
$34
Boehringer Ingelheim Pharmaceuticals, Inc.
$33
USWM, LLC
$33
US WorldMeds, LLC
$33
Alfasigma USA, Inc.
$32
Daiichi Sankyo Inc.
$31
Vertical Pharmaceuticals, LLC
$30
Grifols USA, LLC
$28
E.R. Squibb & Sons, L.L.C.
$27
SCILEX PHARMACEUTICALS INC.
$25
RedHill Biopharma Inc.
$25
Aytu BioScience, Inc
$24
Valinor Pharma, LLC
$23
Noven Therapeutics, LLC
$22
Acerus Pharmaceuticals Corporation
$21
Shionogi Inc
$21
OWP Pharmaceuticals, Inc.
$20
Astellas Pharma US Inc
$19
CSL Behring
$19
Novo Nordisk Inc
$18
Optos, Inc.
$18
Sentynl Therapeutics, Inc.
$17
ARBOR PHARMACEUTICALS, INC.
$17
Aytu Bioscience, Inc
$17
BIODELIVERY SCIENCES INTERNATIONAL, INC.
$16
Top 3 companies account for 24.6% of all-time payments
Associated products mentioned in payments ›
ABILIFY ASIMTUFII · ABILIFY MAINTENA · ABILIFY MYCITE · ADHANSIA XR · APLENZIN · APRETUDE · ARISTADA · Auvelity · BELBUCA · BELSOMRA · BREZTRI · BRINTELLIX · BRIXADI · Biktarvy · CABENUVA · CAPLYTA · CHANTIX · CITALOPRAM · COBENFY · DOVATO · Dayvigo · Dyanavel XR · EGRIFTA · EMGALITY · Evekeo · Evzio · FANAPT · FARXIGA · Fanapt · GRALISE · HETLIOZ · Hizentra · INGREZZA · INVEGA SUSTENNA · INVEGA TRINZA · ISENTRESS · JULUCA · LATUDA · LOREEV XR · LORZONE · LUCEMYRA · LYBALVI · Levorphanol · Lucemyra/Lofexidine · MAVYRET · MOUNJARO · MOVANTIK · MYDAYIS · MYRBETRIQ · Mavyret · Morphabond ER · Movantik · Mytesi · NEUROSTAR TMS THERAPY · NEUROSTAR TMS THERAPY SYSTEM · NOCDURNA · NURTEC ODT · Natesto · Otezla · Otrexup · PANORAMIC OPHTHALMOSCOPE · PERSERIS · PIFELTRO · PREZCOBIX · PREZISTA · QELBREE · QULIPTA · QUVIVIQ · RELEXXII · RELISTOR · REXULTI · RUKOBIA · SECUADO · SEROSTIM · SERTRALINE HCL · SPRAVATO · SUBLOCADE · SUBOXONE SUBLINGUAL FILM · SUBVENITE · SUNOSI · SYMTUZA · Serostim · Sunosi · Symproic · Symtuza · TRADJENTA · TRINTELLIX · TRIUMEQ · TROGARZO · TRULICITY · Trintellix · UBRELVY · UZEDY · VRAYLAR · VYVANSE · Vivitrol · Vyvanse · WELLBUTRIN · Wegovy · XIFAXAN · XYOSTED · Xembify · ZIMHI · ZTLido · Zubsolv
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 8% for optician in CA.
Geographic Context
Opticians within 10 mi
1,542
Per 100K population
15.7
County median income
$87,760
Nearest hospital
CEDARS-SINAI MEDICAL CENTER
0.8 mi
0.8 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Honzel is a clinical cardiology specialist, with above-average Medicare volume (top 28% in CA), with low-engagement industry engagement in the top 8% of CA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Honzel experienced with anti-nausea injection (ondansetron/zofran)?
Based on Medicare claims data, Dr. Honzel performed 968 anti-nausea injection (ondansetron/zofran) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Honzel receive payments from pharmaceutical companies?
Yes. Dr. Honzel received a total of $24,398 from 70 companies across 1,201 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Honzel's costs compare to other opticians in Beverly Hills?
Dr. Honzel's average Medicare payment per service is $33. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Honzel) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Opticians in Beverly Hills
Browse opticians in Beverly Hills ranked by procedure volume and transparency data.
Highest volume
Top Opticians in CA
Opticians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Opticians in CA
Which CA opticians receive the most from drug and device companies.
By company
Gilead Sciences, Inc. Payments to Doctors
See all physicians who received payments from Gilead Sciences, Inc.
By company
ViiV Healthcare Company Payments to Doctors
See all physicians who received payments from ViiV Healthcare Company.
By company
Lundbeck LLC Payments to Doctors
See all physicians who received payments from Lundbeck LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology